All Posts
Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
11 Apr, 2022 | 01:58h | UTCInvited Commentary: How to interpret the total number of SARS-CoV-2 infections – The Lancet
Commentary on Twitter (thread – click for more)
Estimating #SARSCoV2 infections across the world is fraught with difficulties, hence the novel approach in the above study.@KayokoShioda & @B_Lopman discuss findings, interpretations, & implications. https://t.co/ua9arLXDOq
— The Lancet (@TheLancet) April 10, 2022
Review: Gastrointestinal post-acute COVID-19 syndrome.
11 Apr, 2022 | 01:49h | UTCGastrointestinal post-acute COVID-19 syndrome – Nature Reviews Gastroenterology & Hepatology
Commentary on Twitter
NEW! COMMENT
Gastrointestinal post-acute COVID-19 syndromehttps://t.co/SDAOnQSEp4#COVID19 #LongCovid pic.twitter.com/CUSoUt0azy
— Nature Reviews Gastroenterology & Hepatology (@NatRevGastroHep) April 9, 2022
RCT: Effect of Gram Stain–Guided initial antibiotic therapy on clinical response in patients with ventilator-associated pneumonia.
11 Apr, 2022 | 01:36h | UTCCommentary: Can Gram Stains Guide Antibiotics for Pneumonia in Critical Care? – Medscape (free registration required)
Commentary on Twitter
RCT found gram stain-guided antibiotic therapy for critically ill patients with VAP was noninferior to guideline-based antibiotics, with a reduction in antipseudomonal & antiMRSA use. https://t.co/1yoHO2pnER
— JAMA Network Open (@JAMANetworkOpen) April 8, 2022
CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study.
11 Apr, 2022 | 01:40h | UTC
Clinical care of severe acute respiratory infections – Tool kit (COVID-19 adaptation, update 2022).
11 Apr, 2022 | 01:45h | UTCClinical care of severe acute respiratory infections – Tool kit – World Health Organization
Commentary on Twitter (thread – click for more)
Updated toolkit for the clinical care of severe acute respiratory infections including:
🔸 severe #pneumonia
🔸 acute respiratory distress syndrome
🔸 sepsis & septic shock👉 https://t.co/ROvKZz12LT pic.twitter.com/LdcNJiJcxA
— World Health Organization (WHO) (@WHO) April 8, 2022
UK clinical guideline for the prevention and treatment of osteoporosis.
11 Apr, 2022 | 01:33h | UTCUK clinical guideline for the prevention and treatment of osteoporosis – Archives of Osteoporosis
Guideline Synopsis: Management of chronic multisymptom illness.
11 Apr, 2022 | 01:29h | UTC
NCCN Guidelines: CAR T-cell–related toxicities in patients with cancer.
11 Apr, 2022 | 01:32h | UTCRelated:
Reviews: CAR T-Cell Therapy Toxicities and Side Effects
Reviews: CAR T-Cell Therapy Toxicities and Side Effects
Critical Care Management of Chimeric Antigen Receptor T Cell–related Toxicity. Be Aware and Prepared
Reviews: CAR T-Cell Therapy Toxicities and Side Effects
AHA Scientific Statement: addressing social determinants of health and mitigating health disparities across the lifespan in congenital heart disease.
11 Apr, 2022 | 01:31h | UTC
Predicting avoidable health care utilization: practical considerations for artificial intelligence/machine learning models in population health.
11 Apr, 2022 | 01:27h | UTC
RCT: Effects of abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer.
11 Apr, 2022 | 01:23h | UTCAbiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design – The Lancet (link to abstract – $ for full-text)
RCT: Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough.
11 Apr, 2022 | 01:22h | UTCEfficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials – The Lancet (link to abstract – $ for full-text)
Commentary on Twitter
For refractory chronic cough or unexplained chronic cough, gefapixant 45 mg twice per day is the first treatment to show efficacy with an acceptable safety profile in phase 3 clinical trials.
New study by Lorcan P McGarvey & colleagues: https://t.co/XnWM75s6lN pic.twitter.com/VyYyRgWTod
— The Lancet (@TheLancet) March 7, 2022
Large database with 10 registries or clinical trials finds valve-in-valve transcatheter aortic valve implantation (TAVI) resulted in similar mortality and stroke rates compared to native valve TAVI.
11 Apr, 2022 | 01:02h | UTCOutcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation – American Journal of Cardiology
M-A: Oxygen targets during mechanical ventilation in the ICU.
11 Apr, 2022 | 01:26h | UTC
M-A: Association of olfactory impairment with all-cause mortality.
11 Apr, 2022 | 01:01h | UTCAssociation of Olfactory Impairment With All-Cause Mortality: A Systematic Review and Meta-analysis – JAMA Otolaryngology-Head & Neck Surgery (free for a limited period)
Invited Commentary: Olfactory Impairment and Mortality—Is Smell Loss Deadly? – JAMA Otolaryngology-Head & Neck Surgery (free for a limited period)
Commentary on Twitter
Metaanalysis found that #olfactory impairment was associated with 52% higher all-cause #mortality, after adjustment for demographics & comorbidities. The ability to smell is an important marker of general health and biological aging. https://t.co/XEhSpjO2hZ @BenjaminKJTan @mysgh
— JAMA Otolaryngology – Head & Neck Surgery (@JAMAOto) April 7, 2022
Perspective: Supervised consumption sites—a tool for reducing risk of overdose deaths and infectious diseases in people who use illicit drugs.
11 Apr, 2022 | 00:59h | UTCSupervised Consumption Sites—A Tool for Reducing Risk of Overdose Deaths and Infectious Diseases in People Who Use Illicit Drugs – JAMA (free for a limited period)
Commentary on Twitter
NYC last fall opened the first 2 US supervised consumption sites, where people can use illicit drugs under the watchful eye of staff trained to reverse overdoses, but such centers have operated elsewhere—sometimes under the radar—for decades. https://t.co/mS7wLZd164
— JAMA (@JAMA_current) April 6, 2022
M-A: Prophylactic therapies for morbidity and mortality after aneurysmal subarachnoid hemorrhage.
11 Apr, 2022 | 00:52h | UTCProphylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials – Stroke (link to abstract – $ for full-text)
Commentary on Twitter
Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials #stroke #AHAJournals https://t.co/GkM5GlFBd7 pic.twitter.com/6ipIaUK5KX
— Stroke AHA/ASA (@StrokeAHA_ASA) April 8, 2022
You must be joking: funny paper titles might lead to more citations.
11 Apr, 2022 | 00:51h | UTCYou must be joking: funny paper titles might lead to more citations – Nature
Original Study (preprint): If this title is funny, will you cite me? Citation impacts of humor and other features of article titles in ecology and evolution – bioRxiv
M-A: Sentinel lymph node biopsy in patients with ductal carcinoma in situ.
11 Apr, 2022 | 00:46h | UTC
Commentary on Twitter
What is the role of #slnb in #dcis?
This #systematicreview included 16 studies/4388 patients.#DCIS associated with v. low rates of axillary + disease.
Palpable disease, tumour necrosis, g3 DCIS may predict +ve SLNB.#some4surgery #breastcancer https://t.co/oNR25Nu9KN pic.twitter.com/orlMF73300— BJS Open (@BjsOpen) April 8, 2022
Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial.
11 Apr, 2022 | 00:50h | UTCOriginal Study: Randomized Trial: Effects of Aspirin for Primary Prevention in Persons with Diabetes
Commentary on Twitter (images under a https://creativecommons.org/licenses/by/4.0/ license)
Does aspirin have an effect on dementia and cognitive function? Discover it in the EHJ!https://t.co/u5X1fxrULk#aspirin #dementia #CVD #ASCEND #trial #diabetes #cardiotwitter @escardio @ESC_Journals pic.twitter.com/TyrnUnf0MN
— EHJ Editor-in-Chief (@ehj_ed) April 8, 2022
M-A: Prehospital risk assessment in patients suspected of non-ST-segment elevation acute coronary syndrome.
11 Apr, 2022 | 00:48h | UTC
Commentary on Twitter
Prehospital risk assessment in patients suspected of non-ST-segment elevation acute coronary syndrome: a systematic review and meta-analysis https://t.co/tsLld9BEJg #ACS #cardiovascular pic.twitter.com/rUCtXId6Cp
— BMJ_Open (@BMJ_Open) April 6, 2022
M-A: Enhanced recovery care vs. traditional care in laparoscopic hepatectomy.
11 Apr, 2022 | 00:43h | UTCRelated:
Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines (some guidelines are free)
M-A: Effect of obesity treatment interventions in preschool children aged 2–6 years.
11 Apr, 2022 | 00:47h | UTC
Internal mammary node irradiation in patients with node-positive early breast cancer: fifteen-year results from the Danish breast cancer group internal mammary node study.
11 Apr, 2022 | 00:41h | UTCInternal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study – Journal of Clinical Oncology (link to abstract – $ for full-text)
Commentary from the author on Twitter (thread – click for more)
Internal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study https://t.co/fwtVF5Z6g7
— Lise Bech Jellesmark Thorsen (@Lise_BJT) April 9, 2022
RCT: In critically ill children requiring noninvasive respiratory support following extubation, high-flow nasal cannula therapy was NOT noninferior to CPAP, resulting in increased time to liberation from respiratory support.
8 Apr, 2022 | 11:07h | UTCEffect of High-Flow Nasal Cannula Therapy vs Continuous Positive Airway Pressure Following Extubation on Liberation From Respiratory Support in Critically Ill Children: A Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Selecting Intermediate Respiratory Support Following Extubation in the Pediatric Intensive Care Unit – JAMA (free for a limited period)
News Release: Trial identifies most effective breathing support for children in intensive care – Imperial College London
Commentary on Twitter
In this study, among critically ill children requiring noninvasive respiratory support following extubation, HFNC vs CPAP failed to meet the criterion for noninferiority for time to liberation from respiratory support. https://t.co/X1lNAO28le #CCR pic.twitter.com/XBnUpsqUNq
— JAMA (@JAMA_current) April 7, 2022


